3-D Matrix is a leading medical device company, which optimises MIT-founded, self-assembling peptide technology to continually innovate and serve healthcare professionals around the globe. One of its flagship products is the haemostatic hydrogel, PuraBond.PuraBond utilises its unique ready-to-use, transparent properties to improve bleeding management and patient outcomes in ENT surgery across a range of procedures, including functional endoscopic sinus surgery (FESS), adult tonsillectomy, and rhinoplasty.PuraBond is indicated for haemostasis in the following situations encountered during surgery, when haemostasis by ligation or standard means is insufficient or impractical:• Bleeding from small blood vessels and oozing from capillaries of the parenchyma and surrounding tissues of solid organs• Oozing from vascular anastomoses to native or artificial vessels, on the surface of blood vessels and surrounding tissues.